| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |